Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

257.53
Delayed Data
As of Jul 31
 +3.25 / +1.28%
Today’s Change
106.00
Today|||52-Week Range
259.99
+79.95%
Year-to-Date

Today’s Trading

Previous close254.28
Today’s open255.30
Day’s range253.35 - 258.96
Volume1,314,040
Average volume (3 months)1,608,164
Market cap$86.8B
Dividend yield--
Data as of 4:03pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+38.30%
Earnings growth (next 5 years)+28.79%
Revenue growth (last year)+43.22%
P/E ratio96.3
Price/Sales5.93
Price/Book16.01

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.05+0.15%
LLYEli Lilly and Co-0.03-0.04%
ABTAbbott Laboratories-0.08-0.16%
CELGCelgene-0.63-0.48%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$2.73
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts